Raymond James reiterates strong buy on Palvella Therapeutics (PVLA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: PVLA) | Delayed: 125.10 -1.29 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.39 | 52 Week High | $ | |||
| Open | $124.60 | 52 Week Low | $ | |||
| Day High | $125.93 | P/E | N/A | |||
| Day Low | $121.34 | EPS | $ | |||
| Volume | 164,225 | |||||
